Cost and Utilization of Behavioral Health Medications Associated with Rescission of an Exemption for Prior Authorization for Severe and Persistent Mental Illness in the Vermont Medicaid Program

BACKGROUND: In recent years, many state Medicaid programs have implemented preferred drug lists (PDL) to control pharmaceutical costs by generating supplemental rebate revenues and directing providers to the most cost-effective treatments. Two states, Michigan and Vermont, sought approval from the C...

Descripción completa

Detalles Bibliográficos
Autores principales: Simeone, Jason C., Marcoux, Rita M., Quilliam, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437379/
https://www.ncbi.nlm.nih.gov/pubmed/20518584
http://dx.doi.org/10.18553/jmcp.2010.16.5.317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437379/
https://www.ncbi.nlm.nih.gov/pubmed/20518584
http://dx.doi.org/10.18553/jmcp.2010.16.5.317

Ejemplares similares